Systemic treatment for pre-treated recurrent/metastatic (R/M) Squamous Cell Carcinoma of the Head and Neck (HNSCC): a comprehensive review of randomized phase III data

被引：0
|
作者：
Roets, Evelyne [1 ]
Govarts, Anouk [1 ]
van Gogh, Evelien [1 ]
Tukanova, Karina [1 ]
Specenier, Pol [1 ,2 ]
机构：
[1] Univ Antwerp, Antwerp, Belgium
[2] Antwerp Univ Hosp, Edegem, Belgium
来源：
ACTA CLINICA BELGICA | 2017年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0011
引用
收藏
页码：14 / 14
页数：1
相关论文
共 50 条
  • [1] Systemic treatment (ST) for untreated recurrent/metastatic (R/M) Squamous Cell Carcinoma of the Head and Neck (HNSCC): a comprehensive review of randomized phase III data
    Tukanova, Karina
    van Gogh, Evelien
    Govarts, Anouk
    Roets, Evelyne
    Specenier, Pol
    ACTA CLINICA BELGICA, 2017, 72 : 12 - 13
  • [2] Evaluation of systemic inflammatory response (SIR) markers in recurrent or metastatic head and neck squamous cell carcinoma (r/m HNSCC)
    Pogorzelski, M.
    Hilser, T.
    Ting, S.
    Vossebein, I
    Gauler, T. C.
    Abendroth, A.
    Lang, S.
    Stuck, B.
    Abu-Jawad, J.
    Stuschke, M.
    Schmid, K. W.
    Schuler, M.
    Kasper, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 307 - 308
  • [3] The effect of opioids on the efficacy of immunotherapy in recurrent/metastatic squamous cell carcinoma of the head and neck (R/M HNSCC).
    Scheff, Nicole N.
    Nilsen, Marci Lee
    Li, Jinhong
    Harris, Alexandria L.
    Swartz, Andrew
    Hsieh, Ronan Wenhan
    Anderson, Jennifer Lynn
    Ferris, Robert L.
    Menk, Ashley
    Delgoffe, Greg M.
    Zandberg, Dan Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [4] Biomarkers and response to pembrolizumab (pembro) in recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC).
    Chow, Laura Quan Man
    Mehra, Ranee
    Haddad, Robert I.
    Mahipal, Amit
    Weiss, Jared
    Berger, Raanan
    Eder, Joseph Paul
    Burtness, Barbara
    Tahara, Makoto
    Keam, Bhumsuk
    Le, Dung T.
    Muro, Kei
    Geva, Ravit
    Chung, Hyun Cheol
    Lin, Chia-Chi
    Ayers, Mark
    Aurora-Garg, Deepti
    Lunceford, Jared K.
    Cheng, Jonathan D.
    Seiwert, Tanguy Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [5] Clinical outcomes with therapies for previously treated recurrent/metastatic head-and-neck squamous cell carcinoma (R/M HNSCC): A systematic literature review
    Lala, Mallika
    Chirovsky, Diana
    Cheng, Jonathan D.
    Mayawala, Kapil
    ORAL ONCOLOGY, 2018, 84 : 108 - 120
  • [6] A phase I/Ib study of lenvatinib and cetuximab in patients with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).
    Dunn, Lara
    Ho, Alan Loh
    Eng, Juliana
    Michel, Loren S.
    Fetten, James Vincent
    Warner, Elizabeth
    Kriplani, Anuja
    Zhi, Wanqing Iris
    Ng, Kenneth K.
    Haque, Sofia
    Pfister, David G.
    Sherman, Eric Jeffrey
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [7] The EXTREME regimen for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC): Treatment outcome in a single institution cohort
    Lynggaard, Charlotte Duch
    Therkildsen, Marianne Hamilton
    Kristensen, Claus Andrup
    Specht, Lena
    ACTA ONCOLOGICA, 2015, 54 (07) : 1071 - U151
  • [8] Sequential Treatment Use in Clinical Practice for US Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
    Zheng, D.
    Black, C. M.
    Hair, G. M.
    Bidadi, B.
    Lerman, N.
    Ai, L.
    Zion, A.
    Zou, L.
    Gao, W.
    Hanna, G. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (05): : E34 - E34
  • [9] Systemic treatment pattern in a large cohort of recurrent/metastatic head and neck squamous cell cancer (r/m HNSCC) patients (pts) treated at a tertiary cancer centre
    Siano, M.
    Desax, M. C.
    Frueh, M.
    Joerger, M.
    Oncology Research and Treatment, 2015, 38 : 186 - 186
  • [10] A phase II clinical trial of camrelizumab combined with cetuximab and chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC)
    Ji, D.
    Sang, Y.
    Liu, X.
    Guo, Y.
    Yang, Y.
    Chen, G.
    Dong, S.
    Wang, Y.
    He, X.
    Ying, H.
    Lu, X.
    Wang, Y.
    Hu, C.
    Ji, Q.
    ANNALS OF ONCOLOGY, 2024, 35 : S626 - S626
12345